Delivery Order SPE2DB24D1104-SPE2DB25FYDQ3
- Not listed
- The Defense Logistics Agency awarded a $14,672.56 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). The contract is structured as a firm fixed price delivery order with a completion date of July 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitively awarded contract. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,675.75 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count), with a firm fixed price and an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract was issued on July 25, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,007.04 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packages of 30 units. This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $16,557.69 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Telmisartan-HCTZ 80-25 mg tablets in 30-count packages. The contract has a performance period through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packages of 30, with a ceiling value of $5,627.91. This is a firm fixed-price delivery order contract with an ultimate completion date of July 21, 2025, and represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 25, 2025, procures Telmisartan-HCTZ 80-25 mg tablets in unit-dose packaging (30 count) for the Defense Logistics Agency (DLA) at a firm fixed price of $1,243.56. The contract is not set-aside and represents a competitive award for pharmaceutical supply to support federal medical procurement needs. Performance will be completed by July 28, 2025, with delivery to AmerisourceBergen's corporate office location in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,507.44, is for the delivery of 4560843381 - Telmisartan-HCTZ 80-12.5 mg tablets in units of 30s. The contract has a firm fixed price and has a completion date of May 8, 2023. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,815.04, is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The contract has a period of performance through December 6, 2024 and is a firm fixed-price delivery order contract. No set-aside designation is noted. AmerisourceBergen is the prime contractor...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,111.53 firm fixed-price order is for Telmisartan-HCTZ 40-12.5 mg tablets, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This $1,584.47 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4567301009 - Telmisartan-HCTZ 80-25 mg Tablet Unit Dose 30s, with a completion date of February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYDQ3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,083.49 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) under a firm fixed price contract. This delivery order, which was competitively awarded with no set-aside designation, was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor vehicle valued through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp supplies comprehensive pharmaceutical products and medical supplies to support military healthcare systems and other government agencies, including the Defense Health Agency and U.S. Coast Guard. The Telmisartan-HCTZ product being delivered under this order is a combination antihypertensive medication commonly used in military and veteran healthcare systems to manage hypertension.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 7/23/25 |